Have a personal or library account? Click to login
Development and evaluation of orally disintegrating tablets containing the mosapride resin complex Cover

Development and evaluation of orally disintegrating tablets containing the mosapride resin complex

Open Access
|Apr 2018

References

  1. 1. M. Ruth, B. Hamelin, K. Röhss and L. Lundell, The effect of mosapride, a novel prokinetic, on acid reflux variables in patients with gastro-oesophageal reflux disease, Aliment. Pharm. Ther.12 (1998) 35–40; https://doi.org/10.1046/j.1365-2036.1998.00268.x10.1046/j.1365-2036.1998.00268.x9692698
  2. 2. Y. Takayuki, T. Hiroaki, M. Atsushi, K. Masataka, S. Kazuhiro and U. Takahiro, Mechanism of controlled drug release from a salting-out taste-masking system, J. Control. Release131 (2008) 47–53; https://doi.org/10.1016/j.jconrel.2008.07.00910.1016/j.jconrel.2008.07.00918680773
  3. 3. A. Siddiqui, R. B. Shah and M. A. Khan, Oseltamivir phosphate-amberlite(TM) IRP 64 ioniccomplexfor taste masking: preparation and chemometric evaluation, J. Pharm. Sci.102 (2013) 1800–1812; https://doi.org/10.1002/jps.2351810.1002/jps.2351823559456
  4. 4. R. B. Shah, M. A. Tawakkul, V. A. Sayeed and M. A. Khan, Complexation between risperidone and amberlite resin by various methods of preparation and binding study, Drug Dev. Ind. Pharm.35 (2009) 1409–1418; https://doi.org/10.3109/0363904090293924710.3109/0363904090293924719929200
  5. 5. Z. Z. Ge, M. Y. Yang, Y. L. Wang, L. Shan and C. S. Gao, Preparation and evaluation of orally disintegrating tablets of taste masked phencynonate HCl using ion-exchange resin, Drug Dev. Ind. Pharm.41 (2015) 934–941; https://doi.org/10.3109/03639045.2014.91452910.3109/03639045.2014.91452924785576
  6. 6. W. Samprasit, P. Opanasopit, P. Akkaramongkolporn, T. Ngawhirunpat, K. Wongsermsina and S. Panomsuka, Preparation and evaluation of taste-masked dextromethorphan oral disintegrating tablet, Pharm. Dev. Technol.17 (2012) 315–320; https://doi.org/10.3109/10837450.2010.53582810.3109/10837450.2010.53582821142821
  7. 7. E. Roblegg, P. Dittrich, K. Haltmeyer and A. Zimmer, Reformulation of a codeine phosphate liquid controlled-release product, Drug Dev. Ind. Pharm.36 (2010) 1454–1462; https://doi.org/10.3109/03639045.2010.48787010.3109/03639045.2010.48787020533890
  8. 8. M. Preis, L. Grother, P. Axe and J. Breitkreutz, In-vitro and in-vivo evaluation of taste-masked cetirizine hydrochloride formulated in oral lyophilisates, Int. J. Pharm. 491 (2015) 8–16; https://doi.org/10.1016/j.ijpharm.2015.06.00210.1016/j.ijpharm.2015.06.00226051543
  9. 9. C. P. Yewale, M. N. Rathib, G. G. Koreb, G. V. Jadhava and M. P. Wagha, Formulation and development of taste masked fast-disintegrating tablets (FDTs) of chlorpheniramine maleate using ion-exchange resins, Pharm. Dev. Technol.18 (2013) 367–376; https://doi.org/10.3109/10837450.2011.62787010.3109/10837450.2011.62787022023351
  10. 10. P. Akkaramongkolporn, T. Ngawhirunpat and P. Opanasopit, Preparation and evaluation of differently sulfonated styrene-divinylbenzene cross-linked copolymer cationic exchange resins as novel carriers for drug delivery, AAPS PharmSciTech.10 (2009) 641–648; https://doi.org/10.1208/s12249-009-9259-510.1208/s12249-009-9259-5269081919452281
  11. 11. A. Siddiqui, R. B. Shah and M. A. Khan, Oseltamivir phosphate-amberlite (TM) IRP 64 ionic complex for taste masking: Preparation and chemometric evaluation, J. Pharm. Sci.102 (2013) 1800–1812; https://doi.org/10.10.1002/jps.2351810.1002/jps.23518
  12. 12. D. Shukla, S. Chakraborty, S. Singh and B. Mishra, Fabrication and evaluation of taste masked resinate of risperidone and its orally disintegrating tablets, Chem. Pharm. Bull.57 (2009) 337–345; https://doi.org/10.1248/cpb.57.33710.1248/cpb.57.337
  13. 13. M. A. Tawakkul, R. B. Shah, A. Zidan, V. A. Sayeed and M. A. Khan, Complexation of risperidone with a taste-masking resin: Novel application of near infra-red and chemical imaging to evaluate complexes, Pharm. Dev. Technol.14 (2009) 409–421; https://doi.org/10.1080/1083745080271266610.1080/10837450802712666
  14. 14. V. K. Suhagiya, A. N. Goyani and R. N. Gupta, Taste masking by ion exchange resin and its new applications: A review, Int. J. Pharm. Sci. Res.1 (2010) 22–37; https://doi.org/10.13040/IJPSR.0975-8232.1(4).22-3710.13040/IJPSR.0975-8232.1(4).22-37
  15. 15. S. Patra, R. Samantaray, S. Pattnaik and B. Barik, Taste masking of Etoricoxib by using ion-exchange resin, Pharm. Dev. Technol.15 (2010) 511–517; https://doi.org/10.3109/1083745090332278710.3109/1083745090332278719845450
  16. 16. A. Solaiman, A. S. Suliman, S. Shinde, S. Naz and A. A. Elkordy, Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscarmellose sodium and Disintequick MCC-25, Int. J. Pharm. 501 (2016) 87–95; https://doi.org/10.1016/j.ijpharm.2016.01.06510.1016/j.ijpharm.2016.01.06526827922
  17. 17. M. Sugimoto, K. Matsubara, Y. Koida and M. Kobayashi, The preparation of rapidly disintegrating tablets in the mouth, Pharm. Dev. Technol.6 (2001) 487–493; https://doi.org/10.1081/PDT-12000028710.1081/PDT-12000028711775950
  18. 18. Y. Kuno, K. Masazumi, S. Ando and H. Nakagami, Evaluation of rapidly disintegrating tablets manufactured by phase transition of sugar alcohols, J. Control. Release105 (2005) 16–22; https://doi.org/10.1016/j.jconrel.005.01.01810.1016/j.jconrel.2005.01.018
  19. 19. B. Daihom, A. Alayoubi, D. J. Ma, L. J. Wang, S. Mishra, R. Helms and H. Almoazen, Development and physicochemical characterization of clindamycin resinate for taste masking in pediatrics, Drug Dev. Ind. Pharm. 42 (2016) 1600–1608; https://doi.org/10.3109/03639045.2016.116010410.3109/03639045.2016.116010426928944
  20. 20. H. Sohi, Y. Sultana and R. K. Khar, Taste masking technologies in oral pharmaceuticals: recent developments and approaches, Drug Dev. Ind. Pharm.30 (2004) 429–448; https://doi.org/10.1081/DDC-12003747710.1081/DDC-120037477
  21. 21. C. de C Bergamaschi, L. A. Berto, P. C. Venâncio, K. Cogo, M. Franz-Montan, R. H. L. Motta, M. P. Santamaria and F. C. Groppo, Concentrations of metronidazole in human plasma and saliva after tablet or gel administration, J. Pharm. Pharmacol.66 (2014) 40–47; https://doi.org/10.1111/jphp.1216110.1111/jphp.1216124341948
  22. 22. F. Gut, W. Schiek, W. E. Haefeli, I. Walter-Sack and J. Burhenne, Cation exchange resins as pharmaceutical carriers for methylene blue: binding and release, Eur. J. Pharm. Biopharm.69 (2008) 582–587; https://doi.org/10.1016/j.ejpb.2007.12.01610.1016/j.ejpb.2007.12.01618226881
DOI: https://doi.org/10.2478/acph-2018-0017 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 159 - 170
Accepted on: Jan 15, 2018
|
Published on: Apr 26, 2018
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2018 Tong Wu, Guanhua Wang, Caihong Shi, Jinghan Li, Na Zhao, Zihao Dong, Weisan Pan, Xiangrong Zhang, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.